These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34176437)

  • 1. Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies.
    Khan A; Mohammad T; Shamsi A; Hussain A; Alajmi MF; Husain SA; Iqbal MA; Hassan MI
    J Biomol Struct Dyn; 2022; 40(20):10319-10331. PubMed ID: 34176437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high-affinity inhibitors of pyruvate dehydrogenase kinase-3: towards therapeutic management of cancer.
    Mohammad T; Arif K; Alajmi MF; Hussain A; Islam A; Rehman MT; Hassan I
    J Biomol Struct Dyn; 2021 Feb; 39(2):586-594. PubMed ID: 31903847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New natural inhibitors of hexokinase 2 (HK2): Steroids from Ganoderma sinense.
    Bao F; Yang K; Wu C; Gao S; Wang P; Chen L; Li H
    Fitoterapia; 2018 Mar; 125():123-129. PubMed ID: 29305912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Study of Hexokinase 2 (HK2) Inhibitors.
    Wang S; Zhuang Y; Xu J; Tong Y; Li X; Dong C
    Anticancer Agents Med Chem; 2023; 23(7):736-746. PubMed ID: 36278443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
    Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
    J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy.
    Hassan MI; Anjum D; Mohammad T; Alam M; Khan MS; Shahwan M; Shamsi A; Yadav DK
    J Biomol Struct Dyn; 2023 Dec; 41(20):10558-10568. PubMed ID: 36495308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A virtual screening investigation to identify bioactive natural compounds as potential inhibitors of cyclin-dependent kinase 9.
    Atiya A; Shahidi H; Mohammad T; Sharaf SE; Abdulmonem WA; Ashraf GM; Elasbali AM; Alharethi SH; Alhumaydhi FA; Baeesa SS; Rehan M; Shamsi A; Shahwan M
    J Biomol Struct Dyn; 2023 Nov; 41(19):10202-10213. PubMed ID: 36562191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
    Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
    J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying potential inhibitors of C-X-C motif chemokine ligand10 against vitiligo: structure-based virtual screening, molecular dynamics simulation, and principal component analysis.
    Khan MKA; Alouffi S; Ahmad S
    J Biomol Struct Dyn; 2024 Sep; 42(15):8045-8062. PubMed ID: 37565326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering Mutational Impacts on c-Src-HK2 Interaction in Colorectal Cancer Progression, and Identification of Potential Phytocompounds Inhibitors: A Molecular Simulation and Free Energy Calculation Approach.
    Suleman M; Faizullah ; Khan A; Mohammad Sayaf A; Alghamdi A; Alghamdi SA; Alissa M; Alghamdi A; Crovella S
    Curr Med Chem; 2024 Aug; ():. PubMed ID: 39253929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
    Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and simulation studies of phytocompounds derived from Centella asiatica and Andrographis paniculata against hexokinase II as mitocan agents.
    Swargiary G; Mani S
    Mitochondrion; 2021 Nov; 61():138-146. PubMed ID: 34606995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target.
    Ferreira JC; Khrbtli AR; Shetler CL; Mansoor S; Ali L; Sensoy O; Rabeh WM
    J Biol Chem; 2021; 296():100071. PubMed ID: 33187984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin PCL inhibits the Warburg effect of PC3 cells by combining with EGFR and inhibiting HK2.
    Zhang H; Du X; Sun TT; Wang CL; Li Y; Wu SZ
    Oncol Rep; 2017 Mar; 37(3):1765-1771. PubMed ID: 28098871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study.
    Shahroz MM; Sharma HK; Altamimi ASA; Alamri MA; Ali A; Ali A; Alqahtani S; Altharawi A; Alabbas AB; Alossaimi MA; Riadi Y; Firoz A; Afzal O
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35208955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hexokinase 2: The preferential target of trehalose-6-phosphate over hexokinase 1.
    Magalhães RSS; Boechat FC; Brasil AA; Neto JRM; Ribeiro GD; Paranhos LH; Neves de Souza N; Vieira T; Outeiro TF; Neves BC; Eleutherio ECA
    J Cell Biochem; 2022 Nov; 123(11):1808-1816. PubMed ID: 35944097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach.
    Alotaibi BS; Joshi J; Hasan MR; Khan MS; Alharethi SH; Mohammad T; Alhumaydhi FA; Elasbali AM; Hassan MI
    J Biomol Struct Dyn; 2023; 41(14):6749-6758. PubMed ID: 35965440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach.
    Agarwal S; Kashaw SK
    J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive insights into plant-based compounds as fibroblast growth factor receptor 1 inhibitors: a combined molecular docking and dynamics simulation study.
    Almoyad MAA; Wahab S; Ansari MN; Ahmad W; Hani U; Chandra S
    J Biomol Struct Dyn; 2024 Apr; ():1-10. PubMed ID: 38669200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.